Minimus Spine Enrolls 30th Subject to Randomized Study Comparing Triojection® to Discectomy

Minimus Spine, the developer and manufacturer of the Triojection System, a novel system intended to facilitate the treatment of disc herniations with an intradiscal injection of ozone gas, announced that it has enrolled the 30th subject into its 50-patient randomized study comparing Triojection to discectomy

Comment
expand_more expand_less